Corporate News
Titan Biotech schedules board meeting to review Q1 financial results with BSE Ltd As on : 05-Aug-26  13:08

Titan Biotech Limited will hold a board meeting on Thursday, August 13, 2026, to consider and approve unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026, according to a filing with the BSE Ltd. The trading window for designated persons of the company has been closed since Wednesday, July 1, 2026, and will remain closed until 48 hours after the outcome of the board meeting is declared.